Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.

[1]  D. Salerno,et al.  Flecainide versus quinidine: results of a multicenter trial. , 1984, The American journal of cardiology.

[2]  L. Horowitz,et al.  Influence of left ventricular dysfunction on flecainide therapy. , 1987, Journal of the American College of Cardiology.

[3]  J. Bigger,et al.  Prevalence, characteristics and significance of ventricular tachycardia (three or more complexes) detected with ambulatory electrocardiographic recording in the late hospital phase of acute myocardial infarction. , 1981, The American journal of cardiology.

[4]  L. Wilkins.  Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial. , 1983, Circulation.

[5]  J. Goldberg,et al.  Ventricular premature beats and mortality after myocardial infarction. , 1977, The New England journal of medicine.

[6]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[7]  T. Peter,et al.  Effect on survival after myocardial infarction of long-term treatment with phenytoin. , 1978, British heart journal.

[8]  J. Anderson,et al.  Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide. , 1986, Journal of the American College of Cardiology.

[9]  J. Gottdiener,et al.  Treatment of Frequent Ventricular Arrhythmia with Encainide: Assessment Using Serial Ambulatory Electrocardiograms, Intracardiac Electrophysiologic Studies, Treadmill Exercise Tests, and Radionuclide Cineangiographic Studies , 1982, Circulation.

[10]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[11]  C. Furberg.  Effect of antiarrhythmic drugs on mortality after myocardial infarction. , 1983, The American journal of cardiology.

[12]  J P Miller,et al.  The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. , 1984, Circulation.

[13]  H T Davis,et al.  Ventricular Ectopic Beats and Their Relation to Sudden and Nonsudden Cardiac Death After Myocardial Infarction , 1979, Circulation.

[14]  A. Jaffe,et al.  Risk factors for sudden death after acute myocardial infarction: two-year follow-up. , 1984, The American journal of cardiology.

[15]  R. Campbell,et al.  ORAL MEXILETINE IN HIGH-RISK PATIENTS AFTER MYOCARDIAL INFARCTION , 1980, The Lancet.

[16]  L. Rydén,et al.  Prophylaxis of ventricular tachyarrhythmias with intravenous and oral tocainide in patients with and recovering from acute myocardial infarction. , 1980, American heart journal.

[17]  F. Morady.  Management of ventricular tachycardia. , 1987, Chest.

[18]  P. Macfarlane,et al.  A prospective randomized trial of tocainide in patients following myocardial infarction. , 1980, American heart journal.

[19]  Parker Je.  Letter: Postoperative immunosuppression. , 1974 .

[20]  J. Kjekshus,et al.  A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes. , 1984, The American journal of cardiology.

[21]  J. Fleiss,et al.  Risk stratification and survival after myocardial infarction. , 1983, The New England journal of medicine.